MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues
Author(s):
Tony Yao, Patrick T. Rudak, Céline M. Laumont, Alex R. Michaud, Rasheduzzaman Rashu, Natasha N. Knier, Paula J. Foster, Hamish E.G. McWilliam, Jose A. Villadangos, Brad H. Nelson, Gabriel E. DiMattia, Trevor G. Shepherd, S. M.Mansour Haeryfar
Details:
Cancer Immunology, Immunotherapy, Volume 71, Issue 5, 2022-05-01
Article Link: Click here
Affiliations:
- The University of British Columbia
- Western University
- University of Victoria
- British Columbia Cancer Agency
- Lawson Health Research Institute
- Robarts Research Institute
- Department of Microbiology & Immunology
- Department of Biochemistry and Pharmacology
- Verspeeten Family Cancer Centre
- The Mary & John Knight Translational Ovarian Cancer Research Unit

